Navigation Links
CLENERGEN - One of India's Largest Biomass Power Generating Companies and a Global Specialist in the Cultivation and the Production of Sustainable Biomass Feedstock - is Available for Meetings in New York From June 20th Until June 30th

NEW YORK, June 20, 2011 /PRNewswire/ -- Clenergen Corporation (OTCQB: CRGE - BOERSE FRANKFURT: 9CE)

Clenergen offers strategic clean energy generation and supply of biomass feedstock to address the requirement for renewable and sustainable supplies of electricity. They have assembled an experienced managerial, engineering and technical team capable of increasing the efficiency levels of existing combustion steam biomass power plants along with the implementation of second generation gasification and anaerobic digestion technologies. This ten day visit is a unique opportunity to meet the founder of Clenergen  - Mark Quinn – live in New York, or via exclusive conference calls.


The Company has identified two species of tree and bamboo suited for dedicated energy crop plantations for highly efficient biomass production. Additionally, Clenergen has applied a Tree Adaption Process (TAP), which is designed to rapidly increase the rate of growth by up to 40% per annum, resulting in an economically viable source of biomass for generating a renewable source of electricity. Through the direct supply of biomass feedstock, the cost of production is reduced by as much as 30%, resulting in increased operational efficiencies and a cost competitive supply advantage over other sources of renewable energy.

Clenergen has an enviable position as the leading converter of biomass to energy in India and has plans to expand in this space, building on the existing government and business relationships they currently have developed. Clenergen has furthermore operations in the Philippines and Guyana with strong relationships on the African continent. 

Clenergen has spent many years building their current business reality and should be poised to move to the next level of sales and profitability. The company has recently restructured its Board of Directors in preparation for its expected institutional fundraising efforts in North America.  


Clenergen embraces more than any other company the principles of Sustainability with a focus on making local access to energy available to both developed and developing nations, all while converting wasteland into greenery and therefore fight soil erosion, increase the generation of oxygen and the absorption of CO2 emissions.

More on Clenergen

Clenergen Corporation is a publicly traded company with its common stock quoted in the USA on the OTCQB Market (Symbol: CRGE) and in Germany on the First Quotation Board, Open Market of the Frankfurt Stock Exchange (Symbol: 9CE). Clenergen offers strategic clean energy generation and supply of biomass feedstock to address the requirement for renewable and sustainable supplies of electricity. 

Clenergen has developed a unique modular system for gasification and localized plantation management. Clenergen also plans to provide biomass feedstock for producing wood pellets for co firing with coal to produce low emission electricity. 

Clenergen Corporation uses biomass feedstock to implement sustainable supplies of clean energy  for captive end users, islands, mining companies, government or privately-owned power grid systems and other end users. The "Distributed Environmental Power System" marries significant proprietary  advancements in plant science with proven long standing engineering technologies to achieve this goal. 

For further information on Clenergen Corporation and its products and services, go to:  Contact Pamela Peeters at 917 / 696 6264 or for more information and appointments.

More on Cooper Global Communications, our Strategic Investment Relations Firm

Cooper Global Communications is a New York based, full service Investor Relations Firm. With over 35 years of experience, CGC partners with public and emerging public companies to maximize shareholder value by implementing an aggressive investor and media relations program. Contact Richard Cooper,  President of CGC at 212 / 317 1400 for investor related questions. (

SOURCE Clenergen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Ion Channel Targets, Booth 5
2. Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
3. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
4. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
5. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
6. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
7. Lumidigm Biometric Sensor Included in Popular Science Best of What's New for 2008 : Venus Series Fingerprint Sensor Called a Breakthrough Product by the World's Largest Science and Technology Magazine
8. Angela Shen-Hsieh of Visual I
9. O Named to Board of Directors of AIGA: Oldest and Largest Membership Organization for Designers
10. China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility
11. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
Post Your Comments:
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Disappearing forests ... the lives of over 5.5 million people each year. Especially those living in larger ... startup Treepex - based in one of the most pollution-affected countries globally - decided ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
Breaking Biology Technology:
(Date:8/15/2017)... 15 2017   ivWatch LLC , a medical device company ... today announced receipt of its ISO 13485 Certification, the global standard ... Organization for Standardization (ISO®). ... Model 400 Continuous Monitoring device for the early detection of IV ... "This is an important milestone for ...
(Date:5/23/2017)... the first robotic gym for the rehabilitation and functional motor sense evaluation ... Genoa, Italy . The first 30 robots will be available from ... . The technology was developed and patented at the IIT laboratories ... Technology thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
Breaking Biology News(10 mins):